+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Bleeding Disorders Testing Market Analysis & Forecast to 2024-2034

  • PDF Icon

    Report

  • 200 Pages
  • January 2024
  • Region: Global
  • Erevna Healthcare
  • ID: 5923224
The global bleeding disorders testing market size was estimated to be USD 96.62 billion in 2023 and is expected to reach at USD 221.64 billion by 2034 with a CAGR of 7.84% during the forecast period 2024-2034. The expanding use of artificial intelligence & nanomaterials in the field of testing & diagnosis, rising prevalence of bleeding disorders, surge in technological advancements in the field of diagnosis of blood disorders, increasing awareness regarding the disorders among the population, growing potential of nano diagnostics is leading to a growing number of clinical studies focused on detecting bleeding disorders, rising investment in research & development activities by government organizations are some of the key factors boosting the market growth.

Rising investment in research & development activities by government organizations is predicted to boost the market growth during the forecast period. Research plays a crucial role in driving advancements and innovations in the development of test kits and instruments for diagnosing bleeding disorders like Hemophilia A, Hemophilia B, Von Willebrand Disease, and more. Thus, increased investment in research and development activities is leading to a greater number of launches of testing kits and instruments for bleeding disorders. For instance, in March 2023, The National Hemophilia Foundation has initiated a philanthropic fund called 'Pathway to Cures' with the aim of promoting the advancement of groundbreaking therapies and technologies for hereditary blood disorders.

By product, reagents & consumables was the highest revenue-grossing segment in the global bleeding disorders testing market in 2023 owing to the rising rate of testing is attributed to the development of healthcare infrastructure & improved healthcare access in emerging regions and surge in collaborations within market players. For instance, in March 2023, TruDiagnostic, a health data company, has partnered with NADMED, a Finnish firm specializing in nicotinamide adenine dinucleotide diagnostics, to create an innovative NAD+ blood diagnostic test capable of analyzing NAD+ and NADH levels from a small blood sample, catering to various clinical applications. Additionally, instruments is predicted to grow at fastest CAGR during the forecast period owing to the growing prevalence of bleeding disorders, increasing awareness regarding the bleeding disorders testing options, and increasing technological advancements to improve automation & portable analyzers.

By indication, hemophilia A was the highest revenue-grossing segment in the global bleeding disorders testing market in 2023 owing to the growing prevalence of bleeding disorders such as hemophilia A & B and increasing awareness regarding the availability of diagnostic options. Additionally, Von Willebrand disease is predicted to grow at fastest CAGR during the forecast period owing to the rising focus & efforts to develop guidelines for diagnosis & management of bleeding disorders such as Von Willebrand disease by government bodies & other healthcare organizations, surge in prevalence of Von Willebrand disease, increasing technological advancements, growing number of launches of hematology & hemostasis analyzers. For instance, in July 2022, HORIBA Medical is excited to introduce new additions to its Yumizen H500 & H550 hematology product line, comprising compact benchtop hematology analyzers that offer improved performance, new features, and enhanced benefits.

By end-user, hospitals & clinics was the highest revenue-grossing segment in the global bleeding disorders testing market in 2023 owing to the growing awareness regarding bleeding disorders among the population, increasing prevalence of bleeding disorders, and rising rate of hospitalization, driven by the severity of these conditions, is creating a higher demand for testing instruments & reagents in hospitals & clinics. Additionally, diagnostic centers is predicted to grow at fastest CAGR during the forecast period owing to the surge in technological advancements, surge in healthcare infrastructure, rising launch of new products. For instance, in October 2022, The INNOVANCE VWF Ac assay, a completely automated test created for use with the Sysmex CS-2500 and CS-5100 hemostasis analyzers as well as the Siemens Healthineers BCS XP System, has been released by Siemens Healthineers.

North America region is anticipated for the highest revenue share during the forecast period owing to the surge in prevalence of bleeding disorders, rising number of patient population, increasing launch of testing instruments & devices, and growing regulatory approvals. For instance, in June 2023, BioMarin has obtained approval from the U.S. FDA for its ROCTAVIAN gene therapy product, which is intended for the treatment of severe hemophilia A in adults. Roctavian is administered as a single intravenous infusion. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rising healthcare infrastructure, surge in awareness regarding bleeding disorders testing, and increasing donation programs for bleeding disorders testing. For instance, in April 2022, CSL Behring has made a generous donation of 500 million international units of coagulation factor replacement therapy to support the World Federation of Hemophilia's charitable aid program, aimed at assisting individuals dealing with bleeding disorders.

Segmentation: Bleeding Disorders Testing Market Report 2023 - 2034

Bleeding Disorders Testing Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)

  • Instruments
  • Reagents & Consumables

Bleeding Disorders Testing Market Analysis & Forecast by Indication 2023 - 2034 (Revenue USD Bn)

  • Von Willebrand Disease
  • Hemophilia A & B
  • Idiopathic Thrombocytopenic Purpura
  • Others

Bleeding Disorders Testing Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)

  • Hospitals & Clinics
  • Diagnostic Centers
  • Others

Bleeding Disorders Testing Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
  • Middle East & Africa
  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
2. Introduction
2.1. Market Definition
2.2. Global Bleeding Disorders Testing Market Overview
3. Executive Summary
4. Market Environment Analysis
4.1. Porter’s 5 Forces Analysis
4.2. PESTEL Analysis
4.3. SWOT Analysis
5. Market Dynamics
5.1. Drivers Analysis
5.2. Restraints Analysis
5.3. Opportunities Analysis
5.4. Threats Analysis
5.5. Trend Analysis
6. COVID-19 Impact Analysis
7. Bleeding Disorders Testing Market: Product Estimates & Trend Analysis
7.1. Product Segment Opportunity Analysis
7.2. Instruments
7.2.1. Instruments Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.3. Reagents & Consumables
7.3.1. Reagents & Consumables Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8. Bleeding Disorders Testing Market: Indication Estimates & Trend Analysis
8.1. Indication Segment Opportunity Analysis
8.2. Von Willebrand Disease
8.2.1. Von Willebrand Disease Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3. Hemophilia A & B
8.3.1. Hemophilia A & B Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.4. Idiopathic Thrombocytopenic Purpura
8.4.1. Idiopathic Thrombocytopenic Purpura Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.5. Others
8.5.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9. Bleeding Disorders Testing Market: End-user Estimates & Trend Analysis
9.1. End-user Segment Opportunity Analysis
9.2. Hospitals & Clinics
9.2.1. Hospitals & Clinics Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.3. Diagnostic Centers
9.3.1. Diagnostic Centers Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.4. Others
9.4.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10. Regional Market Analysis
10.1. Regional Market Opportunity Analysis
11. North America Bleeding Disorders Testing Market
11.1. North America Bleeding Disorders Testing Market
11.1.1. North America Bleeding Disorders Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.1.2. North America Bleeding Disorders Testing Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
11.1.3. North America Bleeding Disorders Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
11.1.4. North America Bleeding Disorders Testing Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
11.1.5. North America Bleeding Disorders Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11.2. U.S. Global Bleeding Disorders Testing Market
11.2.1. U.S. Bleeding Disorders Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.2.2. U.S. Bleeding Disorders Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
11.2.3. U.S. Bleeding Disorders Testing Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
11.2.4. U.S. Bleeding Disorders Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11.3. Canada Global Bleeding Disorders Testing Market
11.3.1. Canada Bleeding Disorders Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.3.2. Canada Bleeding Disorders Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
11.3.3. Canada Bleeding Disorders Testing Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
11.3.4. Canada Bleeding Disorders Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12. Europe Global Bleeding Disorders Testing Market
12.1. Europe Global Bleeding Disorders Testing Market
12.1.1. Europe Bleeding Disorders Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.1.2. Europe Bleeding Disorders Testing Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
12.1.3. Europe Bleeding Disorders Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
12.1.4. Europe Bleeding Disorders Testing Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
12.1.5. Europe Bleeding Disorders Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.2. Germany Global Bleeding Disorders Testing Market
12.2.1. Germany Bleeding Disorders Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.2.2. Germany Bleeding Disorders Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
12.2.3. Germany Bleeding Disorders Testing Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
12.2.4. Germany Bleeding Disorders Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.3. UK Global Bleeding Disorders Testing Market
12.3.1. UK Bleeding Disorders Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.3.2. UK Bleeding Disorders Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
12.3.3. UK Bleeding Disorders Testing Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
12.3.4. UK Bleeding Disorders Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.4. France Global Bleeding Disorders Testing Market
12.4.1. France Bleeding Disorders Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.4.2. France Bleeding Disorders Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
12.4.3. France Bleeding Disorders Testing Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
12.4.4. France Bleeding Disorders Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.5. Spain Global Bleeding Disorders Testing Market
12.5.1. Spain Bleeding Disorders Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.5.2. Spain Bleeding Disorders Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
12.5.3. Spain Bleeding Disorders Testing Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
12.5.4. Spain Bleeding Disorders Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.6. Italy Global Bleeding Disorders Testing Market
12.6.1. Italy Bleeding Disorders Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.6.2. Italy Bleeding Disorders Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
12.6.3. Italy Bleeding Disorders Testing Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
12.6.4. Italy Bleeding Disorders Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.7. Rest of Europe Global Bleeding Disorders Testing Market
12.7.1. Rest of Europe Bleeding Disorders Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.7.2. Rest of Europe Bleeding Disorders Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
12.7.3. Rest of Europe Bleeding Disorders Testing Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
12.7.4. Rest of Europe Bleeding Disorders Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13. Asia Pacific Global Bleeding Disorders Testing Market
13.1. Asia Pacific Global Bleeding Disorders Testing Market
13.1.1. Asia Pacific Bleeding Disorders Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.1.2. Asia Pacific Bleeding Disorders Testing Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
13.1.3. Asia Pacific Bleeding Disorders Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
13.1.4. Asia Pacific Bleeding Disorders Testing Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.1.5. Asia Pacific Bleeding Disorders Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.2. Japan Global Bleeding Disorders Testing Market
13.2.1. Japan Bleeding Disorders Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.2.2. Japan Bleeding Disorders Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
13.2.3. Japan Bleeding Disorders Testing Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.2.4. Japan Bleeding Disorders Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.3. China Global Bleeding Disorders Testing Market
13.3.1. China Bleeding Disorders Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.3.2. China Bleeding Disorders Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
13.3.3. China Bleeding Disorders Testing Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.3.4. China Bleeding Disorders Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.4. India Global Bleeding Disorders Testing Market
13.4.1. India Bleeding Disorders Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.4.2. India Bleeding Disorders Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
13.4.3. India Bleeding Disorders Testing Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.4.4. India Bleeding Disorders Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.5. South Korea Global Bleeding Disorders Testing Market
13.5.1. South Korea Bleeding Disorders Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.5.2. South Korea Bleeding Disorders Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
13.5.3. South Korea Bleeding Disorders Testing Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.5.4. South Korea Bleeding Disorders Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.6. Australia Global Bleeding Disorders Testing Market
13.6.1. Australia Bleeding Disorders Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.6.2. Australia Bleeding Disorders Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
13.6.3. Australia Bleeding Disorders Testing Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.6.4. Australia Bleeding Disorders Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.7. Rest of Asia Pacific Global Bleeding Disorders Testing Market
13.7.1. Rest of Asia Pacific Bleeding Disorders Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.7.2. Rest of Asia Pacific Bleeding Disorders Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
13.7.3. Rest of Asia Pacific Bleeding Disorders Testing Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.7.4. Rest of Asia Pacific Bleeding Disorders Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14. Latin America Global Bleeding Disorders Testing Market
14.1. Latin America Global Bleeding Disorders Testing Market
14.1.1. Latin America Bleeding Disorders Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.1.2. Latin America Bleeding Disorders Testing Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
14.1.3. Latin America Bleeding Disorders Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
14.1.4. Latin America Bleeding Disorders Testing Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
14.1.5. Latin America Bleeding Disorders Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.2. Brazil Global Bleeding Disorders Testing Market
14.2.1. Brazil Bleeding Disorders Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.2.2. Brazil Bleeding Disorders Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
14.2.3. Brazil Bleeding Disorders Testing Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
14.2.4. Brazil Bleeding Disorders Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.3. Mexico Global Bleeding Disorders Testing Market
14.3.1. Mexico Bleeding Disorders Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.3.2. Mexico Bleeding Disorders Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
14.3.3. Mexico Bleeding Disorders Testing Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
14.3.4. Mexico Bleeding Disorders Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.4. Argentina Global Bleeding Disorders Testing Market
14.4.1. Argentina Bleeding Disorders Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.4.2. Argentina Bleeding Disorders Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
14.4.3. Argentina Bleeding Disorders Testing Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
14.4.4. Argentina Bleeding Disorders Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.5. Rest of Latin America Global Bleeding Disorders Testing Market
14.5.1. Rest of Latin America Bleeding Disorders Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.5.2. Rest of Latin America Bleeding Disorders Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
14.5.3. Rest of Latin America Bleeding Disorders Testing Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
14.5.4. Rest of Latin America Bleeding Disorders Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15. MEA Global Bleeding Disorders Testing Market
15.1. MEA Global Bleeding Disorders Testing Market
15.1.1. MEA Bleeding Disorders Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.1.2. MEA Bleeding Disorders Testing Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
15.1.3. MEA Bleeding Disorders Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
15.1.4. MEA Bleeding Disorders Testing Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
15.1.5. MEA Bleeding Disorders Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.2. GCC Global Bleeding Disorders Testing Market
15.2.1. GCC Bleeding Disorders Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.2.2. GCC Bleeding Disorders Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
15.2.3. GCC Bleeding Disorders Testing Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
15.2.4. GCC Bleeding Disorders Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.3. South Africa Global Bleeding Disorders Testing Market
15.3.1. South Africa Bleeding Disorders Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.3.2. South Africa Bleeding Disorders Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
15.3.3. South Africa Bleeding Disorders Testing Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
15.3.4. South Africa Bleeding Disorders Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.4. Rest of MEA Global Bleeding Disorders Testing Market
15.4.1. Rest of MEA Bleeding Disorders Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.4.2. Rest of MEA Bleeding Disorders Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
15.4.3. Rest of MEA Bleeding Disorders Testing Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
15.4.4. Rest of MEA Bleeding Disorders Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
16. Competitor Analysis
16.1. Company Market Share Analysis, 2023
16.2. Major Recent Developments
17. Company Profiles
17.1. Siemens Healthcare GmbH
17.2. Medexus Pharma, Inc.
17.3. HORIBA Ltd.
17.4. CSL Limited
17.5. Sysmex Corporation
17.6. Grifols, S.A.
17.7. Abbott
17.8. Takeda Pharmaceutical Company Limited
17.9. Thermo Fisher Scientific Inc
17.10. Novo Nordisk A/S
17.11. Atlas Medical GmbH
17.12. Sanofi
17.13. HYPHEN BioMed
17.14. F. Hoffmann-La Roche Ltd.
17.15. Precision Biologics
17.16. Bayer AG
17.17. Pfizer Inc.
17.18. Octapharma AG
17.19. Other Prominent Players
18. Conclusion19. Recommendations

Companies Mentioned

  • Siemens Healthcare GmbH
  • Medexus Pharma Inc.
  • HORIBA Ltd.
  • CSL Limited
  • Sysmex Corporation
  • Grifols
  • S.A.
  • Abbott
  • Takeda Pharmaceutical Company Limited
  • Thermo Fisher Scientific Inc
  • Novo Nordisk A/S
  • Atlas Medical GmbH
  • Sanofi
  • HYPHEN BioMed
  • F. Hoffmann-La Roche Ltd.
  • Precision Biologics
  • Bayer AG
  • Pfizer Inc.
  • Octapharma AG

Table Information